These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25951762)

  • 1. Worsening heart failure: challenges as a therapeutic target.
    Tang WHW; Grodin JL
    JACC Heart Fail; 2015 May; 3(5):404-407. PubMed ID: 25951762
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiopulmonary Limitation in Hypertrophic Cardiomyopathy: Unscrambling the Rubik's Cube.
    Geske JB; Allison TG; Gersh BJ
    JACC Heart Fail; 2015 May; 3(5):419-421. PubMed ID: 25863971
    [No Abstract]   [Full Text] [Related]  

  • 3. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies.
    Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR;
    JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
    Givertz MM; Teerlink JR; Albert NM; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Fang JC; Hernandez AF; Katz SD; Krishnamani R; Stough WG; Walsh MN; Butler J; Carson PE; Dimarco JP; Hershberger RE; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Starling RC
    J Card Fail; 2013 Jun; 19(6):371-89. PubMed ID: 23743486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study.
    van Deursen VM; Edwards C; Cotter G; Davison BA; Damman K; Teerlink JR; Metra M; Felker GM; Ponikowski P; Unemori E; Severin T; Voors AA
    J Card Fail; 2014 Jun; 20(6):407-13. PubMed ID: 24642379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic variation in heart failure trials: time for scepticism?
    Pitt B; Gheorghiade M
    Eur J Heart Fail; 2014 Jun; 16(6):601-2. PubMed ID: 24865962
    [No Abstract]   [Full Text] [Related]  

  • 7. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
    Cotter G; Metra M; Weatherley BD; Dittrich HC; Massie BM; Ponikowski P; Bloomfield DM; O'Connor CM
    Cardiology; 2010; 115(1):29-36. PubMed ID: 19844102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin: a novel agent for the treatment of acute heart failure.
    Wilson SS; Ayaz SI; Levy PD
    Pharmacotherapy; 2015 Mar; 35(3):315-27. PubMed ID: 25759289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Vegter EL; Schmitter D; Hagemeijer Y; Ovchinnikova ES; van der Harst P; Teerlink JR; O'Connor CM; Metra M; Davison BA; Bloomfield D; Cotter G; Cleland JG; Givertz MM; Ponikowski P; van Veldhuisen DJ; van der Meer P; Berezikov E; Voors AA; Khan MA
    Int J Cardiol; 2016 Dec; 224():231-239. PubMed ID: 27661412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing care for acute heart failure--no time to relax.
    Hernandez AF; Granger CB
    Lancet; 2009 Apr; 373(9673):1401-2. PubMed ID: 19329180
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
    O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M
    Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.
    Schmieder RE; Mitrovic V; Hengstenberg C
    Clin Res Cardiol; 2015 Aug; 104(8):621-31. PubMed ID: 25787721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Worsening Heart Failure in the United States.
    Cooper LB; DeVore AD; Michael Felker G
    Heart Fail Clin; 2015 Oct; 11(4):603-14. PubMed ID: 26462100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function trajectories and clinical outcomes in acute heart failure.
    Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA
    Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin: a new approach for the treatment of acute congestive heart failure.
    Grossman J; Frishman WH
    Cardiol Rev; 2010; 18(6):305-12. PubMed ID: 20926940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure.
    Fonseca C; Maggioni AP; Marques F; Araújo I; Brás D; Langdon RB; Lombardi C; Bettencourt P
    Int J Cardiol; 2018 Jan; 250():215-222. PubMed ID: 29050923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin-2 may offer therapeutic advantages in end-stage heart failure.
    Zhao Z; Liu T; Li G
    Int J Cardiol; 2012 Jun; 157(3):432-3. PubMed ID: 22541981
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.
    Cooper LB; Hammill BG; Sharma PP; DeVore AD; Mentz RJ; Fonarow GC; Pang PS; Curtis LH; Hernandez AF
    Am Heart J; 2015 Dec; 170(6):1124-32. PubMed ID: 26678634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.